Wavewise Analytics Pty Ltd.

Wavewise Analytics Pty Ltd. is an Australian medical technology company based in Melbourne. It is developing non-invasive, continuous monitoring technology intended to help clinicians detect neurological deterioration early, so that life-saving interventions can be delivered at the most critical moments. The company positions itself within brain injury care, aiming to redefine the standard of care for brain health monitoring. According to its official website, Wavewise's technology is designed to empower clinicians with early detection of neurological deterioration. The company describes its offering as innovative, non-invasive and continuous, and frames it as addressing a critical need in the healthcare industry. Its stated mission is to transform brain injury care through smarter, safer tools that improve patient outcomes and support frontline healthcare. The company is led by a team drawn from neuroscience, medical devices and critical care. Publicly listed leadership includes Dr Mary-Beth Brinson as Chief Executive Officer, Kevin Fischer as Chief Financial Officer, Dr Elliot Teo as Head of Research, Dr Sigrid Petautschnig as Senior Neuroscientist, Dr Jack Hellerstedt as Lead Scientist, Dr Sung Wook Chung as Data Scientist, and Dr Barry Dixon as Founder. The board includes Andrew Maxwell as Chair, the Hon Jaala Pulford and Danny Sharp as Non-Executive Directors, alongside Dr Barry Dixon. Wavewise presents itself as both a patient-care innovator and an investment opportunity, inviting investors to "Invest in Wavewise and be part of the future of brain injury care." It also invites healthcare professionals, patient advocates and others to engage through careers, partnerships and other forms of involvement. The company is headquartered in Melbourne, Australia.

Wavewise Analytics Pty Ltd. is an Australian medical technology company headquartered in Melbourne. It was founded by Dr Barry Dixon, who is listed on the company's website as Founder and also serves on its board. The company has assembled a leadership team and board drawn from neuroscience, medical devices and critical care, reflecting its focus on brain injury care. Wavewise's public materials describe a mission to transform brain injury care by developing non-invasive, continuous monitoring technology. The company states that its technology is designed to empower clinicians with early detection of neurological deterioration, enabling life-saving interventions at the most critical moments. It frames this work as addressing a critical need in the healthcare industry and as setting a new standard for patient care. The company presents itself both as a clinical innovator and as an investment opportunity, inviting investors to participate in what it describes as the future of brain injury care. It also invites healthcare professionals, patient advocates and others to engage through careers, partnerships and other forms of involvement. Publicly listed leadership includes Dr Mary-Beth Brinson as Chief Executive Officer, Kevin Fischer as Chief Financial Officer, Dr Elliot Teo as Head of Research, Dr Sigrid Petautschnig as Senior Neuroscientist, Dr Jack Hellerstedt as Lead Scientist and Dr Sung Wook Chung as Data Scientist. The board includes Andrew Maxwell as Chair, the Hon Jaala Pulford and Danny Sharp as Non-Executive Directors, and Dr Barry Dixon as Founder. The company is based in Melbourne, Australia.

Developer of non-invasive, continuous brain monitoring technology positioned to redefine the standard of care in brain injury care and enable early, life-saving clinical intervention.

• Non-invasive continuous brain monitoring technology

  Technology designed to empower clinicians with early detection of neurological deterioration, enabling life-saving interventions at the most critical moments.

1. 1Wavewise Analyticswavewise.com
2. 2About – Wavewise Analyticswavewise.com
3. 3Wavewise Analytics Pty Ltd. (Australia) – Wikidatawikidata.org